Full text here: EASL | The Home of Hepatology To view or add a comment, sign in GLP-1 Receptor Agonists for Kidney Transplant Recipients Nephrology Dialysis Transplantation, 2025;, gfaf199, Published: 30 September 2025 Glucagon-like peptide-1 receptor agonists (GLP-1RA) are incretin-based therapies with demonstrated efficacy in glycemic control, weight reduction, and cardiovascular and renal protection
Phase III trials showed visceral fat reduction of about 12-20% over 26 weeks of daily 2 mg dosing
When combined with a balanced diet and regular activity, Tirzepatide can be a powerful tool to support lasting lifestyle changes
They are dispensed by our partner 503A pharmacies solely pursuant to a valid patient-specific prescription from a licensed healthcare provider
Esophageal monitoring If you have persistent reflux symptoms for more than 3 months despite adequate treatment, or if you have alarm symptoms (difficulty swallowing, pain with swallowing, unintentional weight loss beyond therapeutic effects, anemia), endoscopic evaluation is appropriate